AI assistant
Sending…
AIM ImmunoTech Inc. — Director's Dealing 2017
May 3, 2017
35334_dirs_2017-05-03_dc06372b-0250-42bf-86ae-ef0f1e028752.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2017-05-02
Reporting Person: Springate Wayne S. (Sr VP of Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-02 | Common Stock | P | 15873 | $0.63 | Acquired | 32514 | Direct |